by Valet | Feb 19, 2021 | Blog, Clinical Trial, COVID-19, FDA Approved Clinical Trial
In 2020, Personalized Stem Cells developed and secured FDA approval for a COVID-19 stem cell clinical trial. In October of last year, we announced that we out-licensed our allogeneic stem cell program, including the COVID-19 therapy, to Sorrento Therapeutics....
by Valet | Feb 4, 2021 | Clinical Trial, COVID-19, Press Release
Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, announces that the first patients have received stem cell therapy for the treatment of COVID-19 as part of an FDA approved clinical trial. The ongoing clinical trial and stem cell platform,...
by Valet | Jan 12, 2021 | Clinical Trial, FDA Approved Clinical Trial, Press Release
Personalized Stem Cells, Inc (PSC), an adipose-derived stem cell company, announces that the data collection process is complete for their Phase I FDA approved stem cell clinical trial for the treatment of knee osteoarthritis. In early October 2020, the company...
